Shandra Eisenga Human Cell and Tissue Product Safety Act

This bill (S 3733) requires the U.S. Department of Health and Human Services (HHS) to launch a national education campaign about the risks and benefits of human cell and tissue transplants, targeting both the public and healthcare providers. It establishes civil penalties for violations of safety regulations, including fines up to $20,000 per violation or $10 million total per case, and mandates HHS to review donor screening guidelines within 3 years. The law directly affects tissue establishments, healthcare providers, and patients by strengthening transparency around transplant safety risks like infectious diseases. HHS must also submit a report to Congress within two years detailing improvements needed for FDA oversight of these products.